Michael P. Kozar

667 total citations
26 papers, 463 citations indexed

About

Michael P. Kozar is a scholar working on Public Health, Environmental and Occupational Health, Organic Chemistry and Oncology. According to data from OpenAlex, Michael P. Kozar has authored 26 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Public Health, Environmental and Occupational Health, 7 papers in Organic Chemistry and 7 papers in Oncology. Recurrent topics in Michael P. Kozar's work include Malaria Research and Control (13 papers), Drug Transport and Resistance Mechanisms (7 papers) and Synthesis and Characterization of Heterocyclic Compounds (4 papers). Michael P. Kozar is often cited by papers focused on Malaria Research and Control (13 papers), Drug Transport and Resistance Mechanisms (7 papers) and Synthesis and Characterization of Heterocyclic Compounds (4 papers). Michael P. Kozar collaborates with scholars based in United States, Thailand and Sweden. Michael P. Kozar's co-authors include Victor Meléndez, Lin Ai, Colin Ohrt, Alvin Fox, Brandon Pybus, Alan J. Magill, Jason Sousa, Qigui Li, Larry Walker and Thomas H. Hudson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Geochimica et Cosmochimica Acta and Journal of Medicinal Chemistry.

In The Last Decade

Michael P. Kozar

26 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael P. Kozar United States	13	150	131	127	92	72	26	463
Mark Loyevsky United States	19	349 2.3×	200 1.5×	190 1.5×	169 1.8×	42 0.6×	31	1.0k
Michael H. L. Wong United Kingdom	7	225 1.5×	79 0.6×	197 1.6×	47 0.5×	42 0.6×	7	478
Rina P. M. Wong Australia	9	277 1.8×	58 0.4×	83 0.7×	35 0.4×	73 1.0×	11	397
Christine Latour France	17	289 1.9×	331 2.5×	152 1.2×	66 0.7×	43 0.6×	23	747
Ruth H. Hughes United Kingdom	6	388 2.6×	120 0.9×	79 0.6×	116 1.3×	82 1.1×	6	504
Lisa Xie United States	11	170 1.1×	26 0.2×	78 0.6×	63 0.7×	52 0.7×	18	347
Steven L. Andersen United States	12	377 2.5×	178 1.4×	99 0.8×	40 0.4×	34 0.5×	14	544
Suet C. Leung United Kingdom	8	130 0.9×	104 0.8×	81 0.6×	26 0.3×	18 0.3×	12	279
Liezl Gibhard South Africa	12	176 1.2×	87 0.7×	99 0.8×	32 0.3×	20 0.3×	25	353
Ajay D. Pillai United States	15	423 2.8×	303 2.3×	202 1.6×	212 2.3×	17 0.2×	21	938

Countries citing papers authored by Michael P. Kozar

Since Specialization

Citations

This map shows the geographic impact of Michael P. Kozar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael P. Kozar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael P. Kozar more than expected).

Fields of papers citing papers by Michael P. Kozar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael P. Kozar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael P. Kozar. The network helps show where Michael P. Kozar may publish in the future.

Co-authorship network of co-authors of Michael P. Kozar

This figure shows the co-authorship network connecting the top 25 collaborators of Michael P. Kozar. A scholar is included among the top collaborators of Michael P. Kozar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael P. Kozar. Michael P. Kozar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sousa, Jason, Erin Milner, Dustin Carroll, et al.. (2014). The use of a prodrug approach to minimize potential CNS exposure of next generation quinoline methanols while maintaining efficacy in in vivo animal models. European Journal of Drug Metabolism and Pharmacokinetics. 39(4). 231–236. 3 indexed citations

Kozar, Michael P., Brandon Pybus, Jason Sousa, et al.. (2014). Causal Prophylactic Efficacy of Primaquine, Tafenoquine, and Atovaquone-Proguanil AgainstPlasmodium cynomolgiin a Rhesus Monkey Model. Journal of Parasitology. 100(5). 671–673. 4 indexed citations

Wang, Hongxing, Qigui Li, Jing Zhang, et al.. (2013). Nanoparticle formulations of decoquinate increase antimalarial efficacy against liver stage Plasmodium infections in mice. Nanomedicine Nanotechnology Biology and Medicine. 10(1). 57–65. 24 indexed citations

Jin, Xiannu, Brandon Pybus, Sean R. Marcsisin, et al.. (2013). An LC–MS based study of the metabolic profile of primaquine, an 8-aminoquinoline antiparasitic drug, with an in vitro primary human hepatocyte culture model. European Journal of Drug Metabolism and Pharmacokinetics. 39(2). 139–146. 31 indexed citations

Waterman, Paige, Melissa Barber, Amy Weintrob, et al.. (2012). The elution of colistimethate sodium from polymethylmethacrylate and calcium phosphate cement beads.. PubMed. 41(6). 256–9. 8 indexed citations

Pybus, Brandon, Jason Sousa, Xiannu Jin, et al.. (2012). CYP450 phenotyping and accurate mass identification of metabolites of the 8-aminoquinoline, anti-malarial drug primaquine. Malaria Journal. 11(1). 259–259. 86 indexed citations

Gutteridge, Clare E., Michael P. Kozar, Qigui Li, et al.. (2011). In vitro Biotransformation, in vivo Efficacy and Pharmacokinetics of Antimalarial Chalcones. Pharmacology. 87(1-2). 96–104. 17 indexed citations

Milner, Erin, Jason Sousa, Brandon Pybus, et al.. (2011). Characterization of in vivo metabolites of WR319691, a novel compound with activity against Plasmodium falciparum. European Journal of Drug Metabolism and Pharmacokinetics. 36(3). 151–158. 6 indexed citations

Zhang, Liang, Diana Caridha, Brandon Pybus, et al.. (2011). Antimalarial Activities of New Guanidylimidazole and Guanidylimidazoline Derivatives. Journal of Medicinal Chemistry. 54(19). 6634–6646. 9 indexed citations

10.

Liu, Xianjun, Xihong Wang, Qigui Li, et al.. (2011). Synthesis and Antimalarial Activity of 2-Guanidino-4-oxoimidazoline Derivatives. Journal of Medicinal Chemistry. 54(13). 4523–4535. 22 indexed citations

11.

Zhang, Liang, et al.. (2010). New imidazolidinedione derivatives as antimalarial agents. Bioorganic & Medicinal Chemistry. 19(4). 1541–1549. 13 indexed citations

12.

Shiraki, Hiroaki, Michael P. Kozar, Victor Meléndez, et al.. (2010). Antimalarial Activity of Novel 5-Aryl-8-Aminoquinoline Derivatives. Journal of Medicinal Chemistry. 54(1). 131–142. 66 indexed citations

13.

Meléndez, Victor, et al.. (2008). A facile one pot synthesis of 2, 4‐diamino‐6‐substituted s‐triazine derivatives. Journal of Heterocyclic Chemistry. 45(6). 1673–1678. 1 indexed citations

14.

Kozar, Michael P., Kirsten S. Smith, Jason Sousa, et al.. (2007). Role of Specific Cytochrome P450 Isoforms in the Conversion of Phenoxypropoxybiguanide Analogs in Human Liver Microsomes to Potent Antimalarial Dihydrotriazines. Drug Metabolism and Disposition. 36(2). 380–385. 10 indexed citations

15.

Shearer, Todd, Michael P. Kozar, Michael T. O’Neil, et al.. (2005). In Vitro Metabolism of Phenoxypropoxybiguanide Analogues in Human Liver Microsomes to Potent Antimalarial Dihydrotriazines. Journal of Medicinal Chemistry. 48(8). 2805–2813. 19 indexed citations

16.

Waters, Norman C., Geoffrey S. Dow, & Michael P. Kozar. (2004). Antimalarial compound identification and design: advances in the patent literature, 2000 – 2003. Expert Opinion on Therapeutic Patents. 14(8). 1125–1138. 8 indexed citations

17.

Liang, Xing‐Jie, Jun‐Jie Yin, Paul Wang, et al.. (2003). Changes in biophysical parameters of plasma membranes influence cisplatin resistance of sensitive and resistant epidermal carcinoma cells. Experimental Cell Research. 293(2). 283–291. 27 indexed citations

18.

Harley, William, Michael P. Kozar, & Alvin Fox. (2002). Trace analysis of muramic acid in indoor air using an automated derivatization instrument and GC–MS2 or GC–MS3. Journal of Microbiological Methods. 51(1). 95–104. 7 indexed citations

19.

Kozar, Michael P. & Alvin Fox. (2002). Analysis of a stable halogenated derivative of muramic acid by gas chromatography–negative ion chemical ionization tandem mass spectrometry. Journal of Chromatography A. 946(1-2). 229–238. 5 indexed citations

20.

Kozar, Michael P., et al.. (2001). Lunar dust: a negative control for biomarker analyses of extraterrestrial samples?. Geochimica et Cosmochimica Acta. 65(19). 3307–3317. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact